{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:31:54Z","timestamp":1793460714444,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K18038"],"award-info":[{"award-number":["JP24K18038"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K05950"],"award-info":[{"award-number":["JP21K05950"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11302-026-10177-z","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:38:25Z","timestamp":1787801905000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential expression, activity, and fibroblast growth factor 2-mediated modulation of purine-metabolizing enzymes in cultured cortical astrocytes and microglia"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-2215","authenticated-orcid":false,"given":"Ryota","family":"Eguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Otsuguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"3","key":"10177_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35058521","volume":"2","author":"BS Khakh","year":"2001","unstructured":"Khakh BS (2001) Molecular physiology of P2X receptors and ATP signalling at synapses. Nat Rev Neurosci 2(3):165\u2013174. https:\/\/doi.org\/10.1038\/35058521","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10177_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.neuron.2012.09.024","volume":"76","author":"BS Khakh","year":"2012","unstructured":"Khakh BS, North RA (2012) Neuromodulation by extracellular ATP and P2X receptors in the CNS. Neuron 76(1):51\u201369. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.024","journal-title":"Neuron"},{"key":"10177_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-physiol-020518-114259","volume":"81","author":"R Schmid","year":"2019","unstructured":"Schmid R, Evans RJ (2019) ATP-gated P2X receptor channels: molecular insights into functional roles. Annu Rev Physiol 81:43\u201362. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114259","journal-title":"Annu Rev Physiol"},{"key":"10177_CR4","doi-asserted-by":"publisher","first-page":"105253","DOI":"10.1016\/j.phrs.2020.105253","volume":"162","author":"P Agostinho","year":"2020","unstructured":"Agostinho P, Madeira D, Dias L, Sim\u00f5es AP, Cunha RA, Canas PM (2020) Purinergic signaling orchestrating neuron-glia communication. Pharmacol Res 162:105253. https:\/\/doi.org\/10.1016\/j.phrs.2020.105253","journal-title":"Pharmacol Res"},{"key":"10177_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fncel.2015.00211","volume":"9","author":"F Cavaliere","year":"2015","unstructured":"Cavaliere F, Donno C, D\u2019Ambrosi N (2015) Purinergic signaling: a common pathway for neural and mesenchymal stem cell maintenance and differentiation. Front Cell Neurosci 9:211. https:\/\/doi.org\/10.3389\/fncel.2015.00211","journal-title":"Front Cell Neurosci"},{"key":"10177_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature08296","volume":"461","author":"MR Elliott","year":"2009","unstructured":"Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282\u2013286. https:\/\/doi.org\/10.1038\/nature08296","journal-title":"Nature"},{"key":"10177_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coi.2018.03.026","volume":"52","author":"FD Virgilio","year":"2018","unstructured":"Virgilio FD, Sarti AC, Grassi F (2018) Modulation of innate and adaptive immunity by P2X ion channels. Curr Opin Immunol 52:51\u201359. https:\/\/doi.org\/10.1016\/j.coi.2018.03.026","journal-title":"Curr Opin Immunol"},{"key":"10177_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1146\/annurev.pharmtox.45.120403.095731","volume":"45","author":"BB Fredholm","year":"2005","unstructured":"Fredholm BB, Chen JF, Masino SA, Vaugeois JM (2005) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu Rev Pharmacol Toxicol 45:385\u2013412. https:\/\/doi.org\/10.1146\/annurev.pharmtox.45.120403.095731","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"10177_CR9","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1152\/jn.00230.2017","volume":"118","author":"D Acton","year":"2017","unstructured":"Acton D, Miles GB (2017) Gliotransmission and adenosinergic modulation: insights from mammalian spinal motor networks. J Neurophysiol 118(6):3311\u20133327. https:\/\/doi.org\/10.1152\/jn.00230.2017","journal-title":"J Neurophysiol"},{"issue":"4","key":"10177_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/molecules22040676","volume":"22","author":"J Stockwell","year":"2017","unstructured":"Stockwell J, Jakova E, Cayabyab FS (2017) Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration. Molecules 22(4):676. https:\/\/doi.org\/10.3390\/molecules22040676","journal-title":"Molecules"},{"issue":"1","key":"10177_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014an update. Pharmacol Rev 63(1):1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285","journal-title":"Pharmacol Rev"},{"issue":"9","key":"10177_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hask\u00f3","year":"2008","unstructured":"Hask\u00f3 G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7(9):759\u2013770. https:\/\/doi.org\/10.1038\/nrd2638","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10177_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nri.2016.4","volume":"16","author":"C Cekic","year":"2016","unstructured":"Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16(3):177\u2013192. https:\/\/doi.org\/10.1038\/nri.2016.4","journal-title":"Nat Rev Immunol"},{"key":"10177_CR14","doi-asserted-by":"publisher","first-page":"1343653","DOI":"10.3389\/fcell.2023.1343653","volume":"11","author":"E Shigetomi","year":"2024","unstructured":"Shigetomi E, Sakai K, Koizumi S (2024) Extracellular ATP\/adenosine dynamics in the brain and its role in health and disease. Front Cell Dev Biol 11:1343653. https:\/\/doi.org\/10.3389\/fcell.2023.1343653","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10177_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-021-00766-y","volume":"28","author":"CP Chang","year":"2021","unstructured":"Chang CP, Wu KC, Lin CY, Chern Y (2021) Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. J Biomed Sci 28(1):70. https:\/\/doi.org\/10.1186\/s12929-021-00766-y","journal-title":"J Biomed Sci"},{"issue":"2","key":"10177_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11302-022-09862-6","volume":"18","author":"J Schrader","year":"2022","unstructured":"Schrader J (2022) Ectonucleotidases as bridge between the ATP and adenosine world: reflections on Geoffrey Burnstock. Purinergic Signal 18(2):193\u2013198. https:\/\/doi.org\/10.1007\/s11302-022-09862-6","journal-title":"Purinergic Signal"},{"issue":"6","key":"10177_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cellbi.2006.03.001","volume":"30","author":"N Nedeljkovic","year":"2006","unstructured":"Nedeljkovic N, Bjelobaba I, Subasic S, Lavrnja I, Pekovic S, Stojkov D, Vjestica A, Rakic L, Stojiljkovic M (2006) Up-regulation of ectonucleotidase activity after cortical stab injury in rats. Cell Biol Int 30(6):541\u2013546. https:\/\/doi.org\/10.1016\/j.cellbi.2006.03.001","journal-title":"Cell Biol Int"},{"issue":"1-2","key":"10177_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0006-8993(97)00559-3","volume":"766","author":"N Braun","year":"1997","unstructured":"Braun N, Lenz C, Gillardon F, Zimmermann M, Zimmermann H (1997) Focal cerebral ischemia enhances glial expression of ecto-5\u2019-nucleotidase. Brain Res 766(1\u20132):213\u2013226. https:\/\/doi.org\/10.1016\/s0006-8993(97)00559-3","journal-title":"Brain Res"},{"key":"10177_CR19","doi-asserted-by":"publisher","first-page":"115152","DOI":"10.1016\/j.expneurol.2025.115152","volume":"386","author":"H Zhuang","year":"2025","unstructured":"Zhuang H, Lei W, Wu Q, Zhao S, Zhao Y, Zhang S, Zhao N, Sun J, Liu Y (2025) Overexpressed CD73 attenuates GSDMD-mediated astrocyte pyroptosis induced by cerebral ischemia-reperfusion injury through the A2B\/NF-\u03baB pathway. Exp Neurol 386:115152. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115152","journal-title":"Exp Neurol"},{"issue":"4","key":"10177_CR20","doi-asserted-by":"publisher","first-page":"e47857","DOI":"10.15252\/embr.201947857","volume":"21","author":"QQ Cui","year":"2020","unstructured":"Cui QQ, Hu ZL, Hu YL, Chen X, Wang J, Mao L, Lu XJ, Ni M, Chen JG, Wang F (2020) Hippocampal CD39\/ENTPD1 promotes mouse depression-like behavior through hydrolyzing extracellular ATP. EMBO Rep 21(4):e47857. https:\/\/doi.org\/10.15252\/embr.201947857","journal-title":"EMBO Rep"},{"issue":"1","key":"10177_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/glia.24459","volume":"72","author":"MA Bukvic","year":"2024","unstructured":"Bukvic MA, Laketa D, Dragic M, Lavrnja I, Nedeljkovic N (2024) Expression of functionally distinct ecto-5\u2019-nucleotidase\/CD73 glycovariants in reactive astrocytes in experimental autoimmune encephalomyelitis and neuroinflammatory conditions in vitro. Glia 72(1):19\u201333. https:\/\/doi.org\/10.1002\/glia.24459","journal-title":"Glia"},{"issue":"7","key":"10177_CR22","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1046\/j.1460-9568.2003.02567.x","volume":"17","author":"N Braun","year":"2003","unstructured":"Braun N, S\u00e9vigny J, Mishra SK, Robson SC, Barth SW, Gerstberger R, Hammer K, Zimmermann H (2003) Expression of the ecto-ATPase NTPDase2 in the germinal zones of the developing and adult rat brain. Eur J Neurosci 17(7):1355\u20131364. https:\/\/doi.org\/10.1046\/j.1460-9568.2003.02567.x","journal-title":"Eur J Neurosci"},{"issue":"2","key":"10177_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neuroscience.2005.11.039","volume":"138","author":"MR Wink","year":"2006","unstructured":"Wink MR, Braganhol E, Tamajusuku ASK, Lenz G, Zerbini LF, Libermann TA, S\u00e9vigny J, Battastini AMO, Robson SC (2006) Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2\/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes. Neuroscience 138(2):421\u2013432. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.11.039","journal-title":"Neuroscience"},{"key":"10177_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fphar.2018.00153","volume":"9","author":"M Adzic","year":"2018","unstructured":"Adzic M, Nedeljkovic N (2018) Unveiling the role of ecto-5\u2019-nucleotidase\/CD73 in astrocyte migration by using pharmacological tools. Front Pharmacol 9:153. https:\/\/doi.org\/10.3389\/fphar.2018.00153","journal-title":"Front Pharmacol"},{"issue":"12","key":"10177_CR25","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1111\/j.1460-9568.2000.01342.x","volume":"12","author":"N Braun","year":"2000","unstructured":"Braun N, S\u00e9vigny J, Robson SC, Enjyoji K, Guckelberger O, Hammer K, Virgilio FD, Zimmermann H (2000) Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1\/CD39 expression to microglia and vasculature of the brain. Eur J Neurosci 12(12):4357\u20134366. https:\/\/doi.org\/10.1111\/j.1460-9568.2000.01342.x","journal-title":"Eur J Neurosci"},{"issue":"4","key":"10177_CR26","doi-asserted-by":"publisher","first-page":"e0175012","DOI":"10.1371\/journal.pone.0175012","volume":"12","author":"M Matyash","year":"2017","unstructured":"Matyash M, Zabiegalov O, Wendt S, Matyash V, Kettenmann H (2017) The adenosine generating enzymes CD39\/CD73 control microglial processes ramification in the mouse brain. PLoS ONE 12(4):e0175012. https:\/\/doi.org\/10.1371\/journal.pone.0175012","journal-title":"PLoS ONE"},{"issue":"1","key":"10177_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0896-6273(01)80048-9","volume":"18","author":"X Qian","year":"1997","unstructured":"Qian X, Davis AA, Goderie SK, Temple S (1997) FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron 18(1):81\u201393. https:\/\/doi.org\/10.1016\/S0896-6273(01)80048-9","journal-title":"Neuron"},{"issue":"Pt 1","key":"10177_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.0021-8782.2001.00002.x","volume":"200","author":"DR Goddard","year":"2002","unstructured":"Goddard DR, Berry M, Kirvell SL, Butt AM (2002) Fibroblast growth factor-2 induces astroglial and microglial reactivity in vivo. J Anat 200(Pt 1):57\u201367. https:\/\/doi.org\/10.1046\/j.0021-8782.2001.00002.x","journal-title":"J Anat"},{"issue":"2","key":"10177_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00441-003-0756-7","volume":"313","author":"B Reuss","year":"2003","unstructured":"Reuss B, von Bohlen und Halbach O (2003) Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 313(2):139\u2013157. https:\/\/doi.org\/10.1007\/s00441-003-0756-7","journal-title":"Cell Tissue Res"},{"issue":"2","key":"10177_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139\u2013149. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.01.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"22","key":"10177_CR31","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1242\/dev.037689","volume":"137","author":"K Dorey","year":"2010","unstructured":"Dorey K, Amaya E (2010) FGF signalling: diverse roles during early vertebrate embryogenesis. Development 137(22):3731\u20133742. https:\/\/doi.org\/10.1242\/dev.037689","journal-title":"Development"},{"issue":"3","key":"10177_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","volume":"4","author":"DM Ornitz","year":"2015","unstructured":"Ornitz DM, Itoh N (2015) The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4(3):215\u2013266. https:\/\/doi.org\/10.1002\/wdev.176","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"issue":"2","key":"10177_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jphs.2018.12.002","volume":"139","author":"R Eguchi","year":"2019","unstructured":"Eguchi R, Yamaguchi S, Otsuguro K (2019) Fibroblast growth factor 2 modulates extracellular purine metabolism by upregulating ecto-5\u2019-nucleotidase and adenosine deaminase in cultured rat spinal cord astrocytes. J Pharmacol Sci 139(2):98\u2013104. https:\/\/doi.org\/10.1016\/j.jphs.2018.12.002","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"10177_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11302-020-09731-0","volume":"16","author":"R Eguchi","year":"2020","unstructured":"Eguchi R, Kitano T, Otsuguro K (2020) Fibroblast growth factor 2 upregulates ecto-5\u2019-nucleotidase and adenosine deaminase via MAPK pathways in cultured rat spinal cord astrocytes. Purinergic Signal 16(4):519\u2013527. https:\/\/doi.org\/10.1007\/s11302-020-09731-0","journal-title":"Purinergic Signal"},{"issue":"1","key":"10177_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jphs.2015.04.008","volume":"128","author":"R Eguchi","year":"2015","unstructured":"Eguchi R, Akao S, Otsuguro K, Yamaguchi S, Ito S (2015) Different mechanisms of extracellular adenosine accumulation by reduction of the external Ca2+ concentration and inhibition of adenosine metabolism in spinal astrocytes. J Pharmacol Sci 128(1):47\u201353. https:\/\/doi.org\/10.1016\/j.jphs.2015.04.008","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"10177_CR36","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/j.1476-5381.2010.01002.x","volume":"161","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Otsuguro K, Ohta T, Ito S (2010) Adenosine and inosine release during hypoxia in the isolated spinal cord of neonatal rats. Br J Pharmacol 161(8):1806\u20131816. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01002.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10177_CR37","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-\u0394\u0394CT method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"20","key":"10177_CR38","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1093\/emboj\/17.20.5896","volume":"17","author":"M Mohammadi","year":"1998","unstructured":"Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR (1998) Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J 17(20):5896\u20135904. https:\/\/doi.org\/10.1093\/emboj\/17.20.5896","journal-title":"EMBO J"},{"issue":"7","key":"10177_CR39","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","volume":"3","author":"EJ Morris","year":"2013","unstructured":"Morris EJ, Jha S, Restaino CR, Dayananth P, Zhu H, Cooper A, Carr D, Deng Y, Jin W, Black S, Long B, Liu J, Dinunzio E, Windsor W, Zhang R, Zhao S, Angagaw MH, Pinheiro EM, Desai J, Xiao L, Shipps G, Hruza A, Wang J, Kelly J, Paliwal S, Gao X, Babu BS, Zhu L, Daublain P, Zhang L, Lutterbach BA, Pelletier MR, Philippar U, Siliphaivanh P, Witter D, Kirschmeier P, Bishop WR, Hicklin D, Gilliland DG, Jayaraman L, Zawel L, Fawell S, Samatar AA (2013) Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov 3(7):742\u2013750. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0070","journal-title":"Cancer Discov"},{"issue":"24","key":"10177_CR40","doi-asserted-by":"publisher","first-page":"13681","DOI":"10.1073\/pnas.251194298","volume":"98","author":"BL Bennett","year":"2001","unstructured":"Bennett BL, Sasaki DT, Murray BW, O\u2019Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci U S A 98(24):13681\u201313686. https:\/\/doi.org\/10.1073\/pnas.251194298","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10177_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nm1425","volume":"12","author":"S Okada","year":"2006","unstructured":"Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H (2006) Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12(7):829\u2013834. https:\/\/doi.org\/10.1038\/nm1425","journal-title":"Nat Med"},{"issue":"28","key":"10177_CR42","doi-asserted-by":"publisher","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","volume":"28","author":"JE Herrmann","year":"2008","unstructured":"Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV (2008) STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28(28):7231\u20137243. https:\/\/doi.org\/10.1523\/JNEUROSCI.1709-08.2008","journal-title":"J Neurosci"},{"issue":"1","key":"10177_CR43","doi-asserted-by":"publisher","first-page":"e86851","DOI":"10.1371\/journal.pone.0086851","volume":"9","author":"S Hong","year":"2014","unstructured":"Hong S, Song MR (2014) STAT3 but not STAT1 is required for astrocyte differentiation. PLoS ONE 9(1):e86851. https:\/\/doi.org\/10.1371\/journal.pone.0086851","journal-title":"PLoS ONE"},{"key":"10177_CR44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2018.12.021","volume":"405","author":"S Calovi","year":"2019","unstructured":"Calovi S, Mut-Arbona P, Sperl\u00e1gh B (2019) Microglia and the purinergic signaling system. Neuroscience 405:137\u2013147. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.12.021","journal-title":"Neuroscience"},{"key":"10177_CR45","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3389\/fnins.2019.00410","volume":"13","author":"M Jakovljevic","year":"2019","unstructured":"Jakovljevic M, Lavrnja I, Bozic I, Milosevic A, Bjelobaba I, Savic D, S\u00e9vigny J, Pekovic S, Nedeljkovic N, Laketa D (2019) Induction of NTPDase1\/CD39 by reactive microglia and macrophages is associated with the functional state during EAE. Front Neurosci 13:410. https:\/\/doi.org\/10.3389\/fnins.2019.00410","journal-title":"Front Neurosci"},{"issue":"1","key":"10177_CR46","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41467-025-56093-5","volume":"16","author":"Z Fu","year":"2025","unstructured":"Fu Z, Ganesana M, Hwang P, Tan X, Kinkaid MM, Sun YY, Bian E, Weybright A, Chen HR, Sol-Church K, Eyo UB, Pridans C, Quintana FJ, Robson SC, Kumar P, Venton BJ, Schaefer A, Kuan CY (2025) Microglia modulate the cerebrovascular reactivity through ectonucleotidase CD39. Nat Commun 16(1):956. https:\/\/doi.org\/10.1038\/s41467-025-56093-5","journal-title":"Nat Commun"},{"issue":"3","key":"10177_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Str\u00e4ter N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8(3):437\u2013502. https:\/\/doi.org\/10.1007\/s11302-012-9309-4","journal-title":"Purinergic Signal"},{"issue":"36","key":"10177_CR48","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O\u2019Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929\u201311947. https:\/\/doi.org\/10.1523\/JNEUROSCI.1860-14.2014","journal-title":"J Neurosci"},{"key":"10177_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnana.2018.00083","volume":"12","author":"D Keller","year":"2018","unstructured":"Keller D, Er\u00f6 C, Markram H (2018) Cell densities in the mouse brain: a systematic review. Front Neuroanat 12:83. https:\/\/doi.org\/10.3389\/fnana.2018.00083","journal-title":"Front Neuroanat"},{"issue":"8","key":"10177_CR50","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2009.05.001","volume":"32","author":"G Perea","year":"2009","unstructured":"Perea G, Navarrete M, Araque A (2009) Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 32(8):421\u2013431. https:\/\/doi.org\/10.1016\/j.tins.2009.05.001","journal-title":"Trends Neurosci"},{"key":"10177_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fncel.2017.00333","volume":"11","author":"M Jakovljevic","year":"2017","unstructured":"Jakovljevic M, Lavrnja I, Bozic I, Savic D, Bjelobaba I, Pekovic S, S\u00e9vigny J, Nedeljkovic N, Laketa D (2017) Down-regulation of NTPDase2 and ADP-sensitive P2 purinoceptors correlate with severity of symptoms during experimental autoimmune encephalomyelitis. Front Cell Neurosci 11:333. https:\/\/doi.org\/10.3389\/fncel.2017.00333","journal-title":"Front Cell Neurosci"},{"key":"10177_CR52","doi-asserted-by":"publisher","first-page":"175909142211020","DOI":"10.1177\/17590914221102068","volume":"14","author":"M Dragic","year":"2022","unstructured":"Dragic M, Mihajlovic K, Adzic M, Jakovljevic M, Kontic MZ, Mitrovi\u0107 N, Laketa D, Lavrnja I, Kipp M, Grkovi\u0107 I, Nedeljkovic N (2022) Expression of ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase2) is negatively regulated under neuroinflammatory conditions in vivo and in vitro. ASN Neuro 14:17590914221102068. https:\/\/doi.org\/10.1177\/17590914221102068","journal-title":"ASN Neuro"},{"key":"10177_CR53","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1742-2094-11-76","volume":"11","author":"M Noda","year":"2014","unstructured":"Noda M, Takii K, Parajuli B, Kawanokuchi J, Sonobe Y, Takeuchi H, Mizuno T, Suzumura A (2014) FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway. J Neuroinflammation 11:76. https:\/\/doi.org\/10.1186\/1742-2094-11-76","journal-title":"J Neuroinflammation"},{"key":"10177_CR54","doi-asserted-by":"publisher","first-page":"115357","DOI":"10.1016\/j.expneurol.2025.115357","volume":"392","author":"WC Hung","year":"2025","unstructured":"Hung WC, Sun WC, Su TC, Lee YJ, Cheng IHJ (2025) FGFR1 agonists alleviate pathology and cognitive impairment in an Alzheimer\u2019s disease mouse model. Exp Neurol 392:115357. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115357","journal-title":"Exp Neurol"},{"issue":"6","key":"10177_CR55","doi-asserted-by":"publisher","first-page":"e100405","DOI":"10.1371\/journal.pone.0100405","volume":"9","author":"R Natarajan","year":"2014","unstructured":"Natarajan R, Singal V, Benes R, Gao J, Chan H, Chen H, Yu Y, Zhou J, Wu P (2014) STAT3 modulation to enhance motor neuron differentiation in human neural stem cells. PLoS ONE 9(6):e100405. https:\/\/doi.org\/10.1371\/journal.pone.0100405","journal-title":"PLoS ONE"},{"issue":"4","key":"10177_CR56","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/sctm.19-0234","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Lin KH, Young TH, Cheng NC (2020) The influence of fibroblast growth factor 2 on the senescence of human adipose-derived mesenchymal stem cells during long-term culture. Stem Cells Transl Med 9(4):518\u2013530. https:\/\/doi.org\/10.1002\/sctm.19-0234","journal-title":"Stem Cells Transl Med"},{"issue":"11","key":"10177_CR57","doi-asserted-by":"publisher","first-page":"6508","DOI":"10.1128\/mcb.17.11.6508","volume":"17","author":"J Chung","year":"1997","unstructured":"Chung J, Uchida E, Grammer TC, Blenis J (1997) STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17(11):6508\u20136516. https:\/\/doi.org\/10.1128\/mcb.17.11.6508","journal-title":"Mol Cell Biol"},{"issue":"19","key":"10177_CR58","doi-asserted-by":"publisher","first-page":"11107","DOI":"10.1073\/pnas.95.19.11107","volume":"95","author":"TK Sengupta","year":"1998","unstructured":"Sengupta TK, Talbot ES, Scherle PA, Ivashkiv LB (1998) Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. Proc Natl Acad Sci U S A 95(19):11107\u201311112. https:\/\/doi.org\/10.1073\/pnas.95.19.11107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10177_CR59","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41419-022-04941-3","volume":"13","author":"ZY Zheng","year":"2022","unstructured":"Zheng ZY, Chu MY, Lin W, Zheng YQ, Xu XE, Chen Y, Liao LD, Wu ZY, Wang SH, Li EM, Xu LY (2022) Blocking STAT3 signaling augments MEK\/ERK inhibitor efficacy in esophageal squamous cell carcinoma. Cell Death Dis 13(5):496. https:\/\/doi.org\/10.1038\/s41419-022-04941-3","journal-title":"Cell Death Dis"},{"issue":"8","key":"10177_CR60","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1158\/0008-5472.CAN-09-3033","volume":"70","author":"AA Dudka","year":"2010","unstructured":"Dudka AA, Sweet SMM, Heath JK (2010) Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. Cancer Res 70(8):3391\u20133401. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3033","journal-title":"Cancer Res"},{"issue":"4","key":"10177_CR61","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2011.132","volume":"19","author":"L Dong","year":"2012","unstructured":"Dong L, Li Y, Cao J, Liu F, Pier E, Chen J, Xu Z, Chen C, Wang RA, Cui R (2012) FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ 19(4):616\u2013622. https:\/\/doi.org\/10.1038\/cdd.2011.132","journal-title":"Cell Death Differ"},{"key":"10177_CR62","doi-asserted-by":"publisher","first-page":"107775","DOI":"10.1016\/j.exer.2019.107775","volume":"187","author":"Z Dong","year":"2019","unstructured":"Dong Z, Santeford A, Ban N, Lee TJ, Smith C, Ornitz DM, Apte RS (2019) FGF2-induced STAT3 activation regulates pathologic neovascularization. Exp Eye Res 187:107775. https:\/\/doi.org\/10.1016\/j.exer.2019.107775","journal-title":"Exp Eye Res"},{"issue":"2","key":"10177_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/1097-4547(20001015)62:2<241::AID-JNR9>3.0.CO;2-D","volume":"62","author":"DJ Messersmith","year":"2000","unstructured":"Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC (2000) Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62(2):241\u2013256. https:\/\/doi.org\/10.1002\/1097-4547(20001015)62:2%3c241::AID-JNR9%3e3.0.CO;2-D","journal-title":"J Neurosci Res"},{"issue":"12","key":"10177_CR64","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.cellbi.2004.08.005","volume":"28","author":"G Chadi","year":"2004","unstructured":"Chadi G, Gomide VC (2004) FGF-2 and S100\u03b2 immunoreactivities increase in reactive astrocytes, but not in microglia, in ascending dopamine pathways following a striatal 6-OHDA-induced partial lesion of the nigrostriatal system. Cell Biol Int 28(12):849\u2013861. https:\/\/doi.org\/10.1016\/j.cellbi.2004.08.005","journal-title":"Cell Biol Int"},{"issue":"1\u20132","key":"10177_CR65","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0006-8993(98)00552-6","volume":"802","author":"K Takami","year":"1998","unstructured":"Takami K, Matsuo A, Terai K, Walker DG, McGeer EG, McGeer PL (1998) Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer\u2019s disease. Brain Res 802(1\u20132):89\u201397. https:\/\/doi.org\/10.1016\/S0006-8993(98)00552-6","journal-title":"Brain Res"},{"key":"10177_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuropharm.2015.09.019","volume":"104","author":"E Beamer","year":"2016","unstructured":"Beamer E, G\u00f6l\u00f6ncs\u00e9r F, Horv\u00e1th G, Bek\u0151 K, Otrokocsi L, Kov\u00e1nyi B, Sperl\u00e1gh B (2016) Purinergic mechanisms in neuroinflammation: an update from molecules to behavior. Neuropharmacology 104:94\u2013104. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.09.019","journal-title":"Neuropharmacology"},{"key":"10177_CR67","doi-asserted-by":"publisher","first-page":"654850","DOI":"10.3389\/fneur.2021.654850","volume":"12","author":"MJ Pietrowski","year":"2021","unstructured":"Pietrowski MJ, Gabr AA, Kozlov S, Blum D, Halle A, Carvalho K (2021) Glial purinergic signaling in neurodegeneration. Front Neurol 12:654850. https:\/\/doi.org\/10.3389\/fneur.2021.654850","journal-title":"Front Neurol"},{"key":"10177_CR68","doi-asserted-by":"publisher","first-page":"102693","DOI":"10.1016\/j.pneurobio.2024.102693","volume":"243","author":"S Carracedo","year":"2024","unstructured":"Carracedo S, Launay A, Dechelle-Marquet PA, Faivre E, Blum D, Delarasse C, Bou\u00e9-Grabot E (2024) Purinergic-associated immune responses in neurodegenerative diseases. Prog Neurobiol 243:102693. https:\/\/doi.org\/10.1016\/j.pneurobio.2024.102693","journal-title":"Prog Neurobiol"},{"issue":"2","key":"10177_CR69","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","volume":"16","author":"JF Chen","year":"2020","unstructured":"Chen JF, Cunha RA (2020) The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease. Purinergic Signal 16(2):167\u2013174. https:\/\/doi.org\/10.1007\/s11302-020-09694-2","journal-title":"Purinergic Signal"},{"issue":"7","key":"10177_CR70","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s00262-023-03430-6","volume":"72","author":"J Bendell","year":"2023","unstructured":"Bendell J, LoRusso P, Overman M, Noonan AM, Kim DW, Strickler JH, Kim SW, Clarke S, George TJ, Grimison PS, Barve M, Amin M, Desai J, Wise-Draper T, Eck S, Jiang Y, Khan AA, Wu Y, Martin P, Cooper ZA, Elgeioushi N, Mueller N, Kumar R, Patel SP (2023) First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors. Cancer Immunol Immunother 72(7):2443\u20132458. https:\/\/doi.org\/10.1007\/s00262-023-03430-6","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10177_CR71","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/1535-7163.MCT-21-0802","volume":"21","author":"D Piovesan","year":"2022","unstructured":"Piovesan D, Tan JBL, Becker A, Banuelos J, Narasappa N, DiRenzo D, Zhang K, Chen A, Ginn E, Udyavar AR, Yin F, Paprcka SL, Purandare B, Park TW, Kimura N, Kalisiak J, Young SW, Powers JP, Schindler U, Sivick KE, Walters MJ (2022) Targeting CD73 with AB680 (Quemliclustat), a novel and potent small-molecule CD73 inhibitor, restores immune functionality and facilitates antitumor immunity. Mol Cancer Ther 21(6):948\u2013959. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0802","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"10177_CR72","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2308849","volume":"389","author":"Y Loriot","year":"2023","unstructured":"Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO (2023) Erdafitinib or chemotherapy in advanced or metastatic urothelial carcinoma. N Engl J Med 389(21):1961\u20131971. https:\/\/doi.org\/10.1056\/NEJMoa2308849","journal-title":"N Engl J Med"},{"issue":"5","key":"10177_CR73","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Cutsem EV, Ji T, Lihou CF, Zhen H, F\u00e9liz L, Vogel A (2020) Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 21(5):671\u2013684. https:\/\/doi.org\/10.1016\/S1470-2045(20)30109-1","journal-title":"Lancet Oncol"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10177-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10177-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:06:25Z","timestamp":1793459185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10177-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10177"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10177-z","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"assertion":[{"value":"30 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal care and experimental protocols were approved by the Committee on Animal Experimentation, Faculty of Veterinary Medicine, Hokkaido University (19\u20130009 and 24\u20130060).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"65"}}